Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study

被引：1
|
作者：
Randall, L. M. [1 ]
Monk, B. J. [1 ]
Darcy, K. M. [2 ]
Tian, C. [2 ]
Burger, R. A. [1 ]
Liao, S. [3 ]
Peters, W. A. [4 ]
Stock, R. A. [5 ]
Fruehauf, J. P. [1 ]
机构：
[1] Univ Calif Irvine, Orange, CA 92668 USA
[2] GOG Stat & Data Ctr, Roswell Pk Canc Inst, Buffalo, NY USA
[3] St Josephs Hosp, Orange, CA USA
[4] Univ Washington, Seattle, WA 98195 USA
[5] Naval Med Ctr, Portsmouth, VA USA
来源：
GYNECOLOGIC ONCOLOGY | 2008年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
46
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [21] The potential benefit of six versus three cycles of chemotherapy in subsets of women with high-risk early-stage epithelial ovarian,cancer: An exploratory analysis of a Gynecologic Oncology Group study
    Chan, J. K.
    Fleming, G.
    Zhang, M.
    Tian, C.
    Kapp, D. S.
    Monk, B. J.
    Herzog, T.
    Bell, J.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S3 - S4
  • [22] RADICAL TRACHELECTOMY FOR EARLY-STAGE CERVICAL CANCER: A SURVEY OF THE SOCIETY OF GYNECOLOGIC ONCOLOGY (SGO) AND GYNECOLOGIC ONCOLOGY FELLOWS-IN-TRAINING
    Churchill, S. J.
    Armbruster, S. D.
    Schmeler, K. M.
    Frumovitz, M.
    Greer, M.
    Garcia, J.
    Redworth, G.
    Ramirez, P. T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 4 - 4
  • [23] Utilization and outcome of systemic chemotherapy for high-risk early-stage cervical cancer.
    Takekuma, Munetaka
    Matsuzaki, Shinya
    Matsuo, Koji
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] Chemotherapy for high-risk early-stage endometrial cancer
    Kodama, Junichi
    Seki, Noriko
    Hiramatsu, Yuji
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2007, 19 (01) : 42 - 47
  • [25] ENDOMETRIAL CANCER - THE HIGH-RISK EARLY-STAGE PATIENT
    MORROW, CP
    WESTERN JOURNAL OF MEDICINE, 1990, 153 (01): : 78 - 79
  • [26] PROGNOSTIC FACTORS IN EARLY-STAGE UTERINE SARCOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    MAJOR, FJ
    BLESSING, JA
    SILVERBERG, SG
    MORROW, CP
    CREASMAN, WT
    CURRIE, JL
    YORDAN, E
    BRADY, MF
    CANCER, 1993, 71 (04) : 1702 - 1709
  • [27] The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: An exploratory analysis of a Gynecologic Oncology Group study
    Chan, John K.
    Tian, Chunqiao
    Fleming, Gini F.
    Monk, Bradley J.
    Herzog, Thomas J.
    Kapp, Daniel S.
    Bell, Jeffrey
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 301 - 306
  • [28] Chemoradiation With Paclitaxel and Carboplatin in High-Risk Cervical Cancer Patients After Radical Hysterectomy: A Korean Gynecologic Oncology Group Study
    Lee, Taek Sang
    Kang, Soon Beom
    Kim, Young Tak
    Park, Byung Joo
    Kim, Yong Man
    Lee, Jong Min
    Kim, Seok Mo
    Kim, Young Tae
    Kim, Jae Hoon
    Kim, Kyung Tai
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (02): : 304 - 310
  • [29] Vaginal cuff brachytherapy in the adjuvant setting for patients with high-risk early-stage cervical cancer
    Mauro, Geovanne Pedro
    Kleine, Rodolpho Truffa
    Severino da Costa, Samantha Cabral
    Carvalho, Heloisa A.
    BRACHYTHERAPY, 2019, 18 (06) : 747 - 752
  • [30] Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors
    Matsuo, Koji
    Mabuchi, Seiji
    Okazawa, Mika
    Kawano, Mahiru
    Kuroda, Hiromasa
    Kamiura, Shoji
    Kimura, Tadashi
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2015, 26 (01) : 3 - 11
12345